Clinical review: Practical recommendations on the management of perioperative heart failure in cardiac surgery

Critical Care

Volumn 14, Issue 2, 2010, Pages

  Mebazaa, Alexandre ^a   Pitsis, Antonis A ^b   Rudiger, Alain ^c   Toller, Wolfgang ^d   Longrois, Dan ^e   Ricksten, Sven Erik ^f   Bobek, Ilona ^g   De Hert, Stefan ^h   Wieselthaler, Georg ⁱ   Schirmer, Uwe ^j   von Segesser, Ludwig K ^k   Sander, Michael ^l   Poldermans, Don ^m   Ranucci, Marco ⁿ   Karpati, Peter C J ^o   Wouters, Patrick ^p   Seeberger, Manfred ^q   Schmid, Edith R ^c   Weder, Walter ^c   Follath, Ferenc ^c  

^a HÔPITAL LARIBOISIÈRE   (France)

^b St Luke's Hospital   (Greece)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d MEDICAL UNIVERSITY OF GRAZ   (Austria)

^e BICHAT HOSPITAL   (France)

^f SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^g SAN BORTOLO HOSPITAL   (Italy)

^h UNIVERSITY OF AMSTERDAM   (Netherlands)

ⁱ MEDICAL UNIVERSITY OF VIENNA   (Austria)

^j RUHR UNIVERSITY BOCHUM   (Germany)

^k LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^l CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^m ERASMUS MEDICAL CENTER   (Netherlands)

ⁿ IRCCS POLICLINICO SAN DONATO   (Italy)

^o CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^p GHENT UNIVERSITY HOSPITAL   (Belgium)

^q UNIVERSITY HOSPITAL BASEL   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AMRINONE; ANESTHETIC AGENT; BRAIN NATRIURETIC PEPTIDE; DOBUTAMINE; ENOXIMONE; LEVOSIMENDAN; MILRINONE; NORADRENALIN; TROPONIN;

AORTA BALLOON; ECHOCARDIOGRAPHY; EXTRACORPOREAL OXYGENATION; HEART ASSIST DEVICE; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE FAILURE; HEART STROKE VOLUME; HEART SURGERY; HEMODYNAMICS; HUMAN; HYPOTENSION; MEDICAL HISTORY; PARAMETER; PERIOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SWAN GANZ CATHETER; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; ORGANIZATION AND MANAGEMENT; PRACTICE GUIDELINE; PREDICTION AND FORECASTING; PROGNOSIS;

CARDIAC SURGICAL PROCEDURES; HEART FAILURE; HUMANS; PERIOPERATIVE CARE; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 78149278970     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc8153     Document Type: Review

References (90)

1. Nieminen MS, Böhm M, Cowie MR, Drexler H, Filippatos GS, Jondeau G, Hasin Y, Lopez-Sendon J, Mebazaa A, Metra M, Rhodes A, Swedberg K, Priori SG, Garcia MA, Blanc JJ, Budaj A, Cowie MR, Dean V, Deckers J, Burgos EF, Lekakis J, Lindahl B, Mazzotta G, Morais J, Oto A, Smiseth OA, Garcia MA, Dickstein K, Albuquerque A, Conthe P, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 2005, 26:384-416. 10.1093/eurheartj/ehi044, 15681577.
2. Rudiger A, Harjola VP, Muller A, Mattila E, Saila P, Nieminen M, Follath F. Acute heart failure: clinical presentation, one-year mortality and prognostic factors. Eur J Heart Fail 2005, 7:662-670. 10.1016/j.ejheart.2005.01.014, 15921809.
3. Siirila-Waris K, Lassus J, Melin J, Peuhkurinen K, Nieminen MS, Harjola VP. Characteristics, outcomes, and predictors of 1-year mortality in patients hospitalized for acute heart failure. Eur Heart J 2006, 27:3011-3017. 10.1093/eurheartj/ehl407, 17127708.
4. Tavazzi L, Maggioni AP, Lucci D, Cacciatore G, Ansalone G, Oliva F, Porcu M. Nationwide survey on acute heart failure in cardiology ward services in Italy. Eur Heart J 2006, 27:1207-1215. 10.1093/eurheartj/ehi845, 16603579.
5. Nieminen MS, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola VP, Hochadel M, Komajda M, Lassus J, Lopez-Sendon JL, Ponikowski P, Tavazzi L, . EuroHeart Survey Investigators; Heart Failure Association, European Society of Cardiology EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J 2006, 27:2725-2736. 10.1093/eurheartj/ehl193, 17000631, EuroHeart Survey Investigators; Heart Failure Association, European Society of Cardiology.
6. Zannad F, Mebazaa A, Juillière Y, Cohen-Solal A, Guize L, Alla F, Rougé P, Blin P, Barlet MH, Paolozzi L, Vincent C, Desnos M, Samii K, . EFICA Investigators Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: The EFICA study. Eur J Heart Fail 2006, 8:697-705. 10.1016/j.ejheart.2006.01.001, 16516552, EFICA Investigators.
7. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Md RN, Ornato JP, Page RL, et al. ACC/AHA TASK FORCE MEMBERS ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation 2007, 116:1971-1996. 10.1161/CIRCULATIONAHA.107.185700, 17901356, ACC/AHA TASK FORCE MEMBERS.
8. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Strömberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, et al. Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology, ESC Committee for Practice Guidelines ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008, 29:2388-2442. 10.1093/eurheartj/ehn309, 18799522, Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology, ESC Committee for Practice Guidelines.
9. Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG, Konstam MA, Mancini DM, Rahko PS, Silver MA, Stevenson LW, Yancy CW. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009, 119:1977-2016. 10.1161/CIRCULATIONAHA.109.192064, 19324967.
10. Rudiger A, Businger F, Streit M, Schmid ER, Maggiorini M, Follath F. Presentation and outcome of critically ill medical and cardiac-surgery patients with acute heart failure. Swiss Med Wkly 2009, 139:110-116.
11. Pae WE, Miller CA, Matthews Y, Pierce WS. Ventricular assist devices for postcardiotomy cardiogenic shock. A combined registry experience. J Thorac Cardiovasc Surg 1992, 104:541-552. discussion 552-553..
12. Tritapepe L, De Santis V, Vitale D, Guarracino F, Pellegrini F, Pietropaoli P, Singer M. Levosimendan pre-treatment improves outcomes in patients undergoing coronary artery bypass graft surgery. Br J Anaesth 2009, 102:198-204. 10.1093/bja/aen367, 19151048.
13. Davila-Roman VG, Waggoner AD, Hopkins WE, Barzilai B. Right ventricular dysfunction in low output syndrome after cardiac operations: assessment by transesophageal echocardiography. Ann Thorac Surg 1995, 60:1081-1086. 10.1016/0003-4975(95)00526-Q, 7574953.
14. Dunser MW, Mayr AJ, Ulmer H, Ritsch N, Knotzer H, Pajk W, Luckner G, Mutz NJ, Hasibeder WR. The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis. Anesth Analg 2001, 93:7-13. 10.1097/00000539-200107000-00003, 11429329.
15. Morales DL, Garrido MJ, Madigan JD, Helman DN, Faber J, Williams MR, Landry DW, Oz MC. A double-blind randomized trial: prophylactic vasopressin reduces hypotension after cardiopulmonary bypass. Ann Thorac Surg 2003, 75:926-930. 10.1016/S0003-4975(02)04408-9, 12645718.
16. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999, 16:9-13. 10.1016/S1010-7940(99)00134-7, 10456395.
17. Rao V, Ivanov J, Weisel RD, Ikonomidis JS, Christakis GT, David TE. Predictors of low cardiac output syndrome after coronary artery bypass. J Thorac Cardiovasc Surg 1996, 112:38-51. 10.1016/S0022-5223(96)70176-9, 8691884.
18. Kazmers A, Cerqueira MD, Zierler RE. Perioperative and late outcome in patients with left ventricular ejection fraction of 35% or less who require major vascular surgery. J Vasc Surg 1988, 8:307-315. 10.1067/mva.1988.avs0080307, 3047443.
19. Bhatti F, Grayson AD, Grotte G, Fabri BM, Au J, Jones M, Bridgewater B. The logistic EuroSCORE in cardiac surgery: how well does it predict operative risk?. Heart 2006, 92:1817-1820. 1861312, 16547206, 10.1136/hrt.2005.083204.
20. Matsuura K, Ogino H, Matsuda H, Minatoya K, Sasaki H, Yagihara T, Kitamura S. Limitations of EuroSCORE for measurement of risk-stratified mortality in aortic arch surgery using selective cerebral perfusion: is advanced age no longer a risk?. Ann Thorac Surg 2006, 81:2084-2087. 10.1016/j.athoracsur.2006.01.018, 16731133.
21. Grossi EA, Schwartz CF, Yu PJ, Jorde UP, Crooke GA, Grau JB, Ribakove GH, Baumann FG, Ursumanno P, Culliford AT, Colvin SB, Galloway AC. High-risk aortic valve replacement: are the outcomes as bad as predicted?. Ann Thorac Surg 2008, 85:102-106. discussion 107., 10.1016/j.athoracsur.2007.05.010, 18154791.
22. Choong CK, Sergeant P, Nashef SA, Smith JA, Bridgewater B. The EuroSCORE risk stratification system in the current era: how accurate is it and what should be done if it is inaccurate?. Eur J Cardiothorac Surg 2009, 35:59-61. 10.1016/j.ejcts.2008.10.009, 19027318.
23. Zheng Z, Li Y, Zhang S, Hu S. The Chinese coronary artery bypass grafting registry study: how well does the EuroSCORE predict operative risk for Chinese population?. Eur J Cardiothorac Surg 2009, 35:54-58. 10.1016/j.ejcts.2008.08.001, 18778949.
24. D'Errigo P, Seccareccia F, Rosato S, Manno V, Badoni G, Fusco D, Perucci CA. Comparison between an empirically derived model and the EuroSCORE system in the evaluation of hospital performance: the example of the Italian CABG Outcome Project. Eur J Cardiothorac Surg 2008, 33:325-333. 10.1016/j.ejcts.2007.12.001, 18201891.
25. Maisel A, Mueller C, Adams K, Anker SD, Aspromonte N, Cleland JG, Cohen-Solal A, Dahlstrom U, DeMaria A, Di Somma S, Filippatos GS, Fonarow GC, Jourdain P, Komajda M, Liu PP, McDonagh T, McDonald K, Mebazaa A, Nieminen MS, Peacock WF, Tubaro M, Valle R, Vanderhyden M, Yancy CW, Zannad F, Braunwald E. State of the art: using natriuretic peptide levels in clinical practice. Eur J Heart Fail 2008, 10:824-839. 10.1016/j.ejheart.2008.07.014, 18760965.
26. Jankowski M. B-type natriuretic peptide for diagnosis and therapy. Recent Pat Cardiovasc Drug Discov 2008, 3:77-83. 10.2174/157489008784705395, 18537757.
27. Hutfless R, Kazanegra R, Madani M, Bhalla MA, Tulua-Tata A, Chen A, Clopton P, James C, Chiu A, Maisel AS. Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. J Am Coll Cardiol 2004, 43:1873-1879. 10.1016/j.jacc.2003.12.048, 15145114.
28. Pedrazzini GB, Masson S, Latini R, Klersy C, Rossi MG, Pasotti E, Faletra FF, Siclari F, Minervini F, Moccetti T, Auricchio A. Comparison of brain natriuretic peptide plasma levels versus logistic EuroSCORE in predicting in-hospital and late postoperative mortality in patients undergoing aortic valve replacement for symptomatic aortic stenosis. Am J Cardiol 2008, 102:749-754. 10.1016/j.amjcard.2008.04.055, 18774001.
29. Eliasdottir SB, Klemenzson G, Torfason B, Valsson F. Brain natriuretic peptide is a good predictor for outcome in cardiac surgery. Acta Anaesthesiol Scand 2008, 52:182-187. 10.1111/j.1399-6576.2007.01451.x, 17949462.
30. Ross S, Foex P. Protective effects of anaesthetics in reversible and irreversible ischaemia-reperfusion injury. Br J Anaesth 1999, 82:622-632.
31. De Hert SG, Turani F, Mathur S, Stowe DF. Cardioprotection with volatile anesthetics: mechanisms and clinical implications. Anesth Analg 2005, 100:1584-1593. 10.1213/01.ANE.0000153483.61170.0C, 15920178.
32. Bein B, Turowski P, Renner J, Hanss R, Steinfath M, Scholz J, Tonner PH. Comparison of xenon-based anaesthesia compared with total intravenous anaesthesia in high risk surgical patients. Anaesthesia 2005, 60:960-967. 10.1111/j.1365-2044.2005.04326.x, 16179039.
33. Conzen PF, Fischer S, Detter C, Peter K. Sevoflurane provides greater protection of the myocardium than propofol in patients undergoing off-pump coronary artery bypass surgery. Anesthesiology 2003, 99:826-833. 10.1097/00000542-200310000-00013, 14508313.
34. De Hert SG, Cromheecke S, ten Broecke PW, Mertens E, De Blier IG, Stockman BA, Rodrigus IE, Linden PJ. Effects of propofol, desflurane, and sevoflurane on recovery of myocardial function after coronary surgery in elderly high-risk patients. Anesthesiology 2003, 99:314-323. 10.1097/00000542-200308000-00013, 12883404.
35. De Hert SG, ten Broecke PW, Mertens E, Van Sommeren EW, De Blier IG, Stockman BA, Rodrigus IE. Sevoflurane but not propofol preserves myocardial function in coronary surgery patients. Anesthesiology 2002, 97:42-49. 10.1097/00000542-200207000-00007, 12131102.
36. De Hert SG, Linden PJ, Cromheecke S, Meeus R, Nelis A, Van Reeth V, ten Broecke PW, De Blier IG, Stockman BA, Rodrigus IE. Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration. Anesthesiology 2004, 101:299-310. 10.1097/00000542-200408000-00009, 15277911.
37. Landoni G, Biondi-Zoccai GG, Zangrillo A, Bignami E, D'Avolio S, Marchetti C, Calabrò MG, Fochi O, Guarracino F, Tritapepe L, De Hert S, Torri G. Desflurane and sevoflurane in cardiac surgery: a meta-analysis of randomized clinical trials. J Cardiothorac Vasc Anesth 2007, 21:502-511. 10.1053/j.jvca.2007.02.013, 17678775.
38. Jakobsen CJ, Berg H, Hindsholm KB, Faddy N, Sloth E. The influence of propofol versus sevoflurane anesthesia on outcome in 10,535 cardiac surgical procedures. J Cardiothorac Vasc Anesth 2007, 21:664-671. 10.1053/j.jvca.2007.03.002, 17905271.
39. Du Toit EF, Muller CA, McCarthy J, Opie LH. Levosimendan: effects of a calcium sensitizer on function and arrhythmias and cyclic nucleotide levels during ischemia/reperfusion in the Langendorff-perfused guinea pig heart. J Pharmacol Exp Ther 1999, 290:505-514.
40. Sonntag S, Sundberg S, Lehtonen LA, Kleber FX. The calcium sensitizer levosimendan improves the function of stunned myocardium after percutaneous transluminal coronary angioplasty in acute myocardial ischemia. J Am Coll Cardiol 2004, 43:2177-2182. 10.1016/j.jacc.2004.02.052, 15193677.
41. Zangrillo A, Biondi-Zoccai G, Mizzi A, Bruno G, Bignami E, Gerli C, De Santis V, Tritapepe L, Landoni G. Levosimendan reduces cardiac troponin release after cardiac surgery: a meta-analysis of randomized controlled studies. J Cardiothorac Vasc Anesth 2009, 23:474-478. 10.1053/j.jvca.2008.11.013, 19217315.
42. De Hert SG, Lorsomradee S, Eede H, Cromheecke S, Linden PJ. A randomized trial evaluating different modalities of levosimendan administration in cardiac surgery patients with myocardial dysfunction. J Cardiothorac Vasc Anesth 2008, 22:699-705. 10.1053/j.jvca.2008.02.019, 18922426.
43. Soeding PE, Royse CF, Wright CE, Royse AG, Angus JA. Inoprotection: the perioperative role of levosimendan. Anaesth Intensive Care 2007, 35:845-862.
44. Buhre W, Weyland A, Schorn B, Scholz M, Kazmaier S, Hoeft A, Sonntag H. Changes in central venous pressure and pulmonary capillary wedge pressure do not indicate changes in right and left heart volume in patients undergoing coronary artery bypass surgery. Eur J Anaesthesiol 1999, 16:11-17.
45. Godje O, Peyerl M, Seebauer T, Lamm P, Mair H, Reichart B. Central venous pressure, pulmonary capillary wedge pressure and intrathoracic blood volumes as preload indicators in cardiac surgery patients. Eur J Cardiothorac Surg 1998, 13:533-539. discussion 539-540., 10.1016/S1010-7940(98)00063-3, 9663534.
46. Kumar A, Anel R, Bunnell E, Habet K, Zanotti S, Marshall S, Neumann A, Ali A, Cheang M, Kavinsky C, Parrillo JE. Pulmonary artery occlusion pressure and central venous pressure fail to predict ventricular filling volume, cardiac performance, or the response to volume infusion in normal subjects. Crit Care Med 2004, 32:691-699. 10.1097/01.CCM.0000114996.68110.C9, 15090949.
47. Shippy CR, Appel PL, Shoemaker WC. Reliability of clinical monitoring to assess blood volume in critically ill patients. Crit Care Med 1984, 12:107-112. 10.1097/00003246-198402000-00005, 6697726.
48. Buhre W, Buhre K, Kazmaier S, Sonntag H, Weyland A. Assessment of cardiac preload by indicator dilution and transoesophageal echocardiography. Eur J Anaesthesiol 2001, 18:662-667.
49. Lichtwarck-Aschoff M, Beale R, Pfeiffer UJ. Central venous pressure, pulmonary artery occlusion pressure, intrathoracic blood volume, and right ventricular end-diastolic volume as indicators of cardiac preload. J Crit Care 1996, 11:180-188. 10.1016/S0883-9441(96)90029-5, 8977994.
50. Wiesenack C, Prasser C, Keyl C, Rodig G. Assessment of intrathoracic blood volume as an indicator of cardiac preload: single transpulmonary thermodilution technique versus assessment of pressure preload parameters derived from a pulmonary artery catheter. J Cardiothorac Vasc Anesth 2001, 15:584-588. 10.1053/jcan.2001.26536, 11687999.
51. Cavallaro F, Sandroni C, Antonelli M. Functional hemodynamic monitoring and dynamic indices of fluid responsiveness. Minerva Anestesiol 2008, 74:123-135.
52. Sander M, Spies CD, Berger K, Grubitzsch H, Foer A, Kramer M, Carl M, von Heymann C. Prediction of volume response under open-chest conditions during coronary artery bypass surgery. Crit Care 2007, 11:R121. 2246213, 18034888, 10.1186/cc6181.
53. Couture P, Denault AY, McKenty S, Boudreault D, Plante F, Perron R, Babin D, Normandin L, Poirier N. Impact of routine use of intraoperative transesophageal echocardiography during cardiac surgery. Can J Anaesth 2000, 47:20-26. 10.1007/BF03020726, 10626713.
54. Mebazaa A, Karpati P, Renaud E, Algotsson L. Acute right ventricular failure - from pathophysiology to new treatments. Intensive Care Med 2004, 30:185-196. 10.1007/s00134-003-2025-3, 14618229.
55. Fellahi JL, Parienti JJ, Hanouz JL, Plaud B, Riou B, Ouattara A. Perioperative use of dobutamine in cardiac surgery and adverse cardiac outcome: propensity-adjusted analyses. Anesthesiology 2008, 108:979-987. 10.1097/ALN.0b013e318173026f, 18497597.
56. Gillies M, Bellomo R, Doolan L, Buxton B. Bench-to-bedside review: Inotropic drug therapy after adult cardiac surgery - a systematic literature review. Crit Care 2005, 9:266-279. 1175868, 15987381, 10.1186/cc3024.
57. Butterworth J, Prielipp RC, Royster RL, Spray BJ, Kon ND, Wallenhaupt SL, Zaloga GP. Dobutamine increases heart rate more than epinephrine in patients recovering from aortocoronary bypass surgery. J Cardiothorac Vasc Anesth 1992, 6:535-541. 10.1016/1053-0770(92)90095-O, 1421064.
58. Fowler MB, Alderman EL, Oesterle SN, Derby G, Daughters GT, Stinson EB, Ingels NB, Mitchell RS, Miller DC. Dobutamine and dopamine after cardiac surgery: greater augmentation of myocardial blood flow with dobutamine. Circulation 1984, 70:I103-111.
59. Gunnicker M, Brinkmann M, Donovan TJ, Freund U, Schieffer M, Reidemeister JC. The efficacy of amrinone or adrenaline on low cardiac output following cardiopulmonary bypass in patients with coronary artery disease undergoing preoperative beta-blockade. Thorac Cardiovasc Surg 1995, 43:153-160. 10.1055/s-2007-1013790, 7570567.
60. Svedjeholm R, Hallhagen S, Ekroth R, Joachimsson PO, Ronquist G. Dopamine and high-dose insulin infusion (glucose-insulin-potassium) after a cardiac operation: effects on myocardial metabolism. Ann Thorac Surg 1991, 51:262-270.
61. Rosseel PM, Santman FW, Bouter H, Dott CS. Postcardiac surgery low cardiac output syndrome: dopexamine or dopamine?. Intensive Care Med 1997, 23:962-968. 10.1007/s001340050439, 9347368.
62. MacGregor DA, Butterworth J, Zaloga CP, Prielipp RC, James R, Royster RL. Hemodynamic and renal effects of dopexamine and dobutamine in patients with reduced cardiac output following coronary artery bypass grafting. Chest 1994, 106:835-841. 10.1378/chest.106.3.835, 7915979.
63. Kikura M, Sato S. The efficacy of preemptive Milrinone or Amrinone therapy in patients undergoing coronary artery bypass grafting. Anesth Analg 2002, 94:22-30. 10.1097/00000539-200201000-00005, 11772795.
64. Rathmell JP, Prielipp RC, Butterworth JF, Williams E, Villamaria F, Testa L, Viscomi C, Ittleman FP, Baisden CE, Royster RL. A multicenter, randomized, blind comparison of amrinone with milrinone after elective cardiac surgery. Anesth Analg 1998, 86:683-690. 10.1097/00000539-199804000-00001, 9539583.
65. Zerkowski HR, Gunnicker M, Freund U, Dieterich HA, Dressler HT, Doetsch N, Schieffer M, Hakim-Meibodi K, Lockhart JD, Reidemeister JC. Low-output syndrome after heart surgery: is a monotherapy with phosphodiesterase-III inhibitors feasible? A comparative study of amrinone and enoximone. Thorac Cardiovasc Surg 1992, 40:371-377. 10.1055/s-2007-1020183, 1290186.
66. Dupuis JY, Bondy R, Cattran C, Nathan HJ, Wynands JE. Amrinone and dobutamine as primary treatment of low cardiac output syndrome following coronary artery surgery: a comparison of their effects on hemodynamics and outcome. J Cardiothorac Vasc Anesth 1992, 6:542-553. 10.1016/1053-0770(92)90096-P, 1421065.
67. Feneck RO, Sherry KM, Withington PS, Oduro-Dominah A. Comparison of the hemodynamic effects of milrinone with dobutamine in patients after cardiac surgery. J Cardiothorac Vasc Anesth 2001, 15:306-315. 10.1053/jcan.2001.23274, 11426360.
68. Tarr TJ, Moore NA, Frazer RS, Shearer ES, Desmond MJ. Haemodynamic effects and comparison of enoximone, dobutamine and dopamine following mitral valve surgery. Eur J Anaesthesiol Suppl 1993, 8:15-24.
69. Al-Shawaf E, Ayed A, Vislocky I, Radomir B, Dehrab N, Tarazi R. Levosimendan or milrinone in the type 2 diabetic patient with low ejection fraction undergoing elective coronary artery surgery. J Cardiothorac Vasc Anesth 2006, 20:353-357. 10.1053/j.jvca.2006.02.012, 16750735.
70. Labriola C, Siro-Brigiani M, Carrata F, Santangelo E, Amantea B. Hemodynamic effects of levosimendan in patients with low-output heart failure after cardiac surgery. Int J Clin Pharmacol Ther 2004, 42:204-211.
71. Siirila-Waris K, Suojaranta-Ylinen R, Harjola VP. Levosimendan in cardiac surgery. J Cardiothorac Vasc Anesth 2005, 19:345-349. 10.1053/j.jvca.2005.03.012, 16130062.
72. Alvarez J, Bouzada M, Fernandez AL, Caruezo V, Taboada M, Rodriguez J, Ginesta V, Rubio J, Garcia-Bengoechea JB, Gonzalez-Juanatey JR. [Hemodynamic effects of levosimendan compared with dobutamine in patients with low cardiac output after cardiac surgery]. Rev Esp Cardiol 2006, 59:338-345. 10.1157/13087055, 16709386.
73. Levin RL, Degrange MA, Porcile R, Salvagio F, Blanco N, Botbol AL, Tanus E, del Mazo CD. [The calcium sensitizer levosimendan gives superior results to dobutamine in postoperative low cardiac output syndrome]. Rev Esp Cardiol 2008, 61:471-479.
74. De Hert SG, Lorsomradee S, Cromheecke S, Linden PJ. The effects of levosimendan in cardiac surgery patients with poor left ventricular function. Anesth Analg 2007, 104:766-773. 10.1213/01.ane.0000256863.92050.d3, 17377079.
75. Michaels AD, McKeown B, Kostal M, Vakharia KT, Jordan MV, Gerber IL, Foster E, Chatterjee K. Effects of intravenous levosimendan on human coronary vasomotor regulation, left ventricular wall stress, and myocardial oxygen uptake. Circulation 2005, 111:1504-1509. 10.1161/01.CIR.0000159252.82444.22, 15781741.
76. Jorgensen K, Bech-Hanssen O, Houltz E, Ricksten SE. Effects of levosimendan on left ventricular relaxation and early filling at maintained preload and afterload conditions after aortic valve replacement for aortic stenosis. Circulation 2008, 117:1075-1081. 10.1161/CIRCULATIONAHA.107.722868, 18268152.
77. Yau TM, Ikonomidis JS, Weisel RD, Mickle DA, Ivanov J, Mohabeer MK, Tumiati L, Carson S, Liu P. Ventricular function after normothermic versus hypothermic cardioplegia. J Thorac Cardiovasc Surg 1993, 105:833-843. discussion 843-844..
78. Teoh KH, Christakis GT, Weisel RD, Fremes SE, Mickle DA, Romaschin AD, Harding RS, Ivanov J, Madonik MM, Ross IM, et al. Accelerated myocardial metabolic recovery with terminal warm blood cardioplegia. J Thorac Cardiovasc Surg 1986, 91:888-895.
79. Christakis GT, Weisel RD, Fremes SE, Ivanov J, David TE, Goldman BS, Salerno TA. Coronary artery bypass grafting in patients with poor ventricular function. Cardiovascular Surgeons of the University of Toronto. J Thorac Cardiovasc Surg 1992, 103:1083-1091. discussion 1091-1092..
80. Fedoruk LM, Kron IL. An unusual case of cardiac dysfunction after left ventricular reconstruction. J Cardiothorac Surg 2006, 1:28. 1584228, 16984656, 10.1186/1749-8090-1-28.
81. Cotter G, Moshkovitz Y, Kaluski E, Milo O, Nobikov Y, Schneeweiss A, Krakover R, Vered Z. The role of cardiac power and systemic vascular resistance in the pathophysiology and diagnosis of patients with acute congestive heart failure. Eur J Heart Fail 2003, 5:443-451. 10.1016/S1388-9842(03)00100-4, 12921805.
82. Helman DN, Morales DL, Edwards NM, Mancini DM, Chen JM, Rose EA, Oz MC. Left ventricular assist device bridge-to-transplant network improves survival after failed cardiotomy. Ann Thorac Surg 1999, 68:1187-1194. 10.1016/S0003-4975(99)00911-X, 10543478.
83. Miller LW, Pagani FD, Russell SD, John R, Boyle AJ, Aaronson KD, Conte JV, Naka Y, Mancini D, Delgado RM, MacGillivray TE, Farrar DJ, Frazier OH, . HeartMate II Clinical Investigators Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 2007, 357:885-896. 10.1056/NEJMoa067758, 17761592, HeartMate II Clinical Investigators.
84. Wieselthaler G, O'Driscoll G, Jansz P, Khaghani A, Strueber M. First clinical experience with the novel HeartWare HVAD pump with hydrodynamically levitated rotor in a multiinstitutional trial. J Heart Lung Transpl 2009,
85. Pons JM, Granados A, Espinas JA, Borras JM, Martin I, Moreno V. Assessing open heart surgery mortality in Catalonia (Spain) through a predictive risk model. Eur J Cardiothorac Surg 1997, 11:415-423. 10.1016/S1010-7940(96)01061-5, 9105802.
86. Roques F, Gabrielle F, Michel P, De Vincentiis C, David M, Baudet E. Quality of care in adult heart surgery: proposal for a self-assessment approach based on a French multicenter study. Eur J Cardiothorac Surg 1995, 9:433-439. 10.1016/S1010-7940(05)80078-8, 7495587.
87. Tu JV, Jaglal SB, Naylor CD. Multicenter validation of a risk index for mortality, intensive care unit stay, and overall hospital length of stay after cardiac surgery. Steering Committee of the Provincial Adult Cardiac Care Network of Ontario. Circulation 1995, 91:677-684.
88. Higgins TL, Estafanous FG, Loop FD, Beck GJ, Blum JM, Paranandi L. Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients. A clinical severity score. JAMA 1992, 267:2344-2348. 10.1001/jama.267.17.2344, 1564774.
89. Parsonnet V, Dean D, Bernstein AD. A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease. Circulation 1989, 79:I3-12.
90. Samuels LE, Kaufman MS, Thomas MP, Holmes EC, Brockman SK, Wechsler AS. Pharmacological criteria for ventricular assist device insertion following postcardiotomy shock: experience with the Abiomed BVS system. J Card Surg 1999, 14:288-293. 10.1111/j.1540-8191.1999.tb00996.x, 10874615.